icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Clinical Added Value
no clinical added value
NEVANAC 1 mg/ ml, eye drops, suspension does not offer any improvement in actual benefit (IAB V) over standard management of postoperative macular oedema associated with cataract surgery in diabetic patients.
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
qpRNzg8NB6a3e4HB
Listen
